Exclusive Commercialization Partnership With Clinigen

for Xervyteg® in aGvHD

Enhancing Survival Through Innovative Immune Modulation

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

August 8, 2025

August 7, 2025: French Tech : Maat Pharma traite les complications de greffe de moelle osseuse – BFM Business (French Only)

July 28, 2025

July 28, 2025: MaaT Pharma Secures €37.5 Million Loan From European Investment Bank (EIB) Marking a New Step in Advancing its Clinical Program in Hemato-Oncology

July 24, 2025

July 24, 2025: MaaT Pharma: Half-year Report to the Liquidity Contract With Kepler Cheuvreux

Like what you see? See more posts

Our upcoming events

Event
August 8, 2025

SFGM-TC 2025

SGGM-TC 2025 - September 18-19, 2025
MaaT Pharma
Event
August 8, 2025

Lyon Pôle Bourse Forum

Lyon Pôle Bourse Forum - September 23, 2025
MaaT Pharma
Event
August 8, 2025

KBC Healthcare Conference 2025

• September 25, 2025 – KBC Healthcare Conference, Brussels
MaaT Pharma

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers